EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

Autor: Ramos-Casals, M., Brito-Zeron, P., Bombardieri, S., Bootsma, H., De Vita, S., Dorner, T., Fisher, B. A., Gottenberg, J. -E., Hernandez-Molina, G., Kocher, A., Kostov, B., Kruize, A. A., Mandl, T., W. -F., Ng, Retamozo, S., Seror, R., Shoenfeld, Y., Siso-Almirall, A., Tzioufas, A. G., Vitali, C., Bowman, S., EULAR-Sjögren Syndrome Task Force Group: Sebastian A, Mariette X., Saraux, A, Vissink, A, Rasmussen, A, Hofauer, B, Armagan, B, Feijoo-Massó, C, Shiboski, Ch, Baldini, C, Vollenweider, C, Sene, D, Hammenfors, D, Isenberg, D, Danda, D, Bartoloni, E

Publikováno v: UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩

International audience; The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in recent decades: treatment decisions remain challenging in clinical practice, without a specific therapeutic target beyond the relief of sym

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39d7e3abfd1ac58830ee8b114a47a6a5
https://pubmed.ncbi.nlm.nih.gov/31780793

American College of Rheumatology Classification Criteria for Sjögren’s Syndrome: A Data-Driven, Expert Consensus Approach in the SICCA Cohort

Autor: Shiboski, SC, Shiboski, CH, Criswell, LA, Baer, AN, Challacombe, S, Lanfranchi, H, Schiødt, M, Umehara, H, Vivino, F, Zhao, Y, Dong, Y, Greenspan, D, Heidenreich, AM, Helin, P, Kirkham, B, Kitagawa, K, Larkin, G, Li, M, Lietman, T, Lindegaard, J, McNamara, N, Sack, K, Shirlaw, P, Sugai, S, Vollenweider, C, Whitcher, J, Wu, A, Zhang, S, Zhang, W, Greenspan, JS, Daniels, TE

We propose new classification criteria for Sjögren's syndrome (SS), which are needed considering the emergence of biologic agents as potential treatments and their associated comorbidity. These criteria target individuals with signs/symptoms suggest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0470517595757a2a9c152152489d1a3c
https://europepmc.org/articles/PMC3349440/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.